Shu Guo

2.2k total citations
82 papers, 1.6k citations indexed

About

Shu Guo is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Shu Guo has authored 82 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 18 papers in Cancer Research and 17 papers in Surgery. Recurrent topics in Shu Guo's work include Mesenchymal stem cell research (14 papers), MicroRNA in disease regulation (11 papers) and Bone Tissue Engineering Materials (11 papers). Shu Guo is often cited by papers focused on Mesenchymal stem cell research (14 papers), MicroRNA in disease regulation (11 papers) and Bone Tissue Engineering Materials (11 papers). Shu Guo collaborates with scholars based in China, United States and South Korea. Shu Guo's co-authors include Shude Yang, Xin Su, Ting Wang, Shuang Tong, Faqing Huang, Peixuan Guo, Qiang Sun, Mengzhu Lv, Siyuan Han and Qiang Sun and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Scientific Reports.

In The Last Decade

Shu Guo

76 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shu Guo China 23 578 365 267 240 210 82 1.6k
Zbigniew Rybak Poland 15 591 1.0× 377 1.0× 354 1.3× 338 1.4× 101 0.5× 73 1.7k
Henry C. Hsia United States 22 514 0.9× 228 0.6× 447 1.7× 325 1.4× 123 0.6× 68 2.1k
Zhangui Tang China 24 888 1.5× 363 1.0× 245 0.9× 212 0.9× 394 1.9× 94 2.0k
Maria Szymonowicz Poland 17 582 1.0× 454 1.2× 324 1.2× 333 1.4× 99 0.5× 73 1.9k
Elena López‐Ruiz Spain 24 409 0.7× 459 1.3× 298 1.1× 162 0.7× 123 0.6× 52 1.4k
Yongsheng Zhou China 26 640 1.1× 594 1.6× 177 0.7× 120 0.5× 257 1.2× 71 1.8k
Jiaming Sun China 27 422 0.7× 819 2.2× 463 1.7× 170 0.7× 149 0.7× 92 2.0k
David Chau United Kingdom 22 439 0.8× 435 1.2× 317 1.2× 134 0.6× 58 0.3× 57 1.8k
Sarah Strauß Germany 21 405 0.7× 246 0.7× 186 0.7× 137 0.6× 88 0.4× 63 1.2k
Sylvia Joussen Germany 23 1.0k 1.8× 356 1.0× 471 1.8× 689 2.9× 245 1.2× 30 2.1k

Countries citing papers authored by Shu Guo

Since Specialization
Citations

This map shows the geographic impact of Shu Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu Guo more than expected).

Fields of papers citing papers by Shu Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shu Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu Guo. The network helps show where Shu Guo may publish in the future.

Co-authorship network of co-authors of Shu Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Shu Guo. A scholar is included among the top collaborators of Shu Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu Guo. Shu Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Wang, Ting, Shu Guo, & Ye Zhang. (2024). Effect of nHA/CS/PLGA delivering adipose stem cell-derived exosomes and bone marrow stem cells on bone healing—in vitro and in vivo studies. Scientific Reports. 14(1). 27502–27502. 3 indexed citations
3.
Zhou, You, et al.. (2024). Application and Perspectives: Magnesium Materials in Bone Regeneration. ACS Biomaterials Science & Engineering. 10(6). 3514–3527. 17 indexed citations
4.
Feng, Ziyi, Xin Su, Ting Wang, et al.. (2023). The Role of Microsphere Structures in Bottom-Up Bone Tissue Engineering. Pharmaceutics. 15(2). 321–321. 11 indexed citations
5.
Zhou, You Lang, Siyu Liu, Wei Wang, et al.. (2021). The miR-204-5p/FOXC1/GDF7 axis regulates the osteogenic differentiation of human adipose-derived stem cells via the AKT and p38 signalling pathways. Stem Cell Research & Therapy. 12(1). 64–64. 31 indexed citations
6.
7.
Feng, Ziyi, Shude Yang, Ting Wang, & Shu Guo. (2021). Effect of Melatonin for Regulating Mesenchymal Stromal Cells and Derived Extracellular Vesicles. Frontiers in Cell and Developmental Biology. 9. 717913–717913. 10 indexed citations
8.
Su, Xin, Ting Wang, & Shu Guo. (2021). Applications of 3D printed bone tissue engineering scaffolds in the stem cell field. Regenerative Therapy. 16. 63–72. 143 indexed citations
9.
Liu, Bo, et al.. (2019). Improving intraoperative storage conditions for autologous bone grafts: An experimental investigation in mice. Journal of Tissue Engineering and Regenerative Medicine. 13(12). 2169–2180. 11 indexed citations
10.
Guo, Shu, et al.. (2019). Surgical Treatment Strategy for Severe Rhinophyma With Bilateral Pedicled Nasolabial Flaps. Journal of Craniofacial Surgery. 30(6). e542–e544. 1 indexed citations
11.
Wang, Chenchao, Jia Shen, Soonchul Lee, et al.. (2018). Peroxisome Proliferator-Activated Receptor-γ Knockdown Impairs Bone Morphogenetic Protein-2–Induced Critical-Size Bone Defect Repair. American Journal Of Pathology. 189(3). 648–664. 7 indexed citations
12.
Guo, Shu, Shuang Tong, Qiang Sun, et al.. (2018). Immunosuppression of Human Adipose-Derived Stem Cells on T Cell Subsets via the Reduction of NF-kappaB Activation Mediated by PD-L1/PD-1 and Gal-9/TIM-3 Pathways. Stem Cells and Development. 27(17). 1191–1202. 43 indexed citations
13.
Guo, Shu, et al.. (2017). Adipose-derived stem cells and hyaluronic acid based gel compatibility, studied in vitro. Molecular Medicine Reports. 16(4). 4095–4100. 12 indexed citations
14.
Geng, Rui, et al.. (2016). The level of soluble programmed death ligand-1 in lung cancer: An exploratory biomarker study. Annals of Oncology. 27. vi22–vi22. 1 indexed citations
15.
Corso, Alessandro, Michel Delforge, Kevin Song, et al.. (2015). HEALTH RESOURCE UTILIZATION WITH CONTINUOUS LENALIDOMIDE TREATMENT (TX) IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM). Haematologica. 100. 24–25. 1 indexed citations
16.
Wang, Yuxin, et al.. (2015). Prognostic significance of in situ and plasma levels of transforming growth factor β1, -2 and -3 in cutaneous melanoma. Molecular Medicine Reports. 11(6). 4508–4512. 11 indexed citations
17.
Wang, Yuxin, et al.. (2014). SUMO1 Genetic Polymorphisms May Contribute to the Risk of Nonsyndromic Cleft Lip With or Without Palate: A Meta-Analysis. Genetic Testing and Molecular Biomarkers. 18(9). 616–624. 13 indexed citations
18.
Wang, Yuxin, et al.. (2013). Transforming Growth Factor-Beta3 Gene Polymorphisms and Nonsyndromic Cleft Lip and Palate Risk: A Meta-Analysis. Genetic Testing and Molecular Biomarkers. 17(12). 881–889. 13 indexed citations
19.
Wang, Yuxin, et al.. (2012). CSMD1 exhibits antitumor activity in A375 melanoma cells through activation of the Smad pathway. APOPTOSIS. 17(9). 927–937. 43 indexed citations
20.
Guo, Shu, et al.. (2010). A Study of Echogenic Regional Anaesthesia Needles in Thiel Cadavers. Minimally Invasive Therapy & Allied Technologies. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026